A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux

The LXR nuclear receptors are intracellular sensors of cholesterol excess and are activated by various oxysterols. LXRs have been shown to regulate multiple genes of lipid metabolism, including ABCA1 (formerly known asABC1). ABCA1 is a lipid pump that effluxes cholesterol and phospholipid out of cel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2002-03, Vol.277 (12), p.10021-10027
Hauptverfasser: Sparrow, Carl P., Baffic, Joanne, Lam, My-Hanh, Lund, Erik G., Adams, Alan D., Fu, Xuan, Hayes, Nancy, Jones, A. Brian, Macnaul, Karen L., Ondeyka, John, Singh, Sheo, Wang, Jianhua, Zhou, Gaochao, Moller, David E., Wright, Samuel D., Menke, John G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10027
container_issue 12
container_start_page 10021
container_title The Journal of biological chemistry
container_volume 277
creator Sparrow, Carl P.
Baffic, Joanne
Lam, My-Hanh
Lund, Erik G.
Adams, Alan D.
Fu, Xuan
Hayes, Nancy
Jones, A. Brian
Macnaul, Karen L.
Ondeyka, John
Singh, Sheo
Wang, Jianhua
Zhou, Gaochao
Moller, David E.
Wright, Samuel D.
Menke, John G.
description The LXR nuclear receptors are intracellular sensors of cholesterol excess and are activated by various oxysterols. LXRs have been shown to regulate multiple genes of lipid metabolism, including ABCA1 (formerly known asABC1). ABCA1 is a lipid pump that effluxes cholesterol and phospholipid out of cells. ABCA1 deficiency causes extremely low high density lipoprotein (HDL) levels, demonstrating the importance of ABCA1 in the formation of HDL. The present work shows that the acetyl-podocarpic dimer (APD) is a potent, selective agonist for both LXRα (NR1H3) and LXRβ (NR1H2). In transient transactivation assays, APD was ∼1000-fold more potent, and yielded ∼6-fold greater maximal stimulation, than the widely used LXR agonist 22-(R)-hydroxycholesterol. APD induced ABCA1mRNA levels, and increased efflux of both cholesterol and phospholipid, from multiple cell types. Gas chromatography-mass spectrometry measurements demonstrated that APD stimulated efflux of endogenous cholesterol, eliminating any possible artifacts of cholesterol labeling. For both mRNA induction and stimulation of cholesterol efflux, APD was found to be more effective than was cholesterol loading. Taken together, these data show that APD is a more effective LXR agonist than endogenous oxysterols. LXR agonists may therefore be useful for the prevention and treatment of atherosclerosis, especially in the context of low HDL levels.
doi_str_mv 10.1074/jbc.M108225200
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18301683</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925819361290</els_id><sourcerecordid>18301683</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-c80f6072270bd99ff3eb6d75186b55aae88bfdbbe79c9be16108da9ef2bc3a013</originalsourceid><addsrcrecordid>eNp1kU1v1DAURS0EokNhyxJ5gdhlsJ0mdpZhVKDSFFALUneWP14mrhK72E6ha_44Hs1IZYM3fpLPvXo6Rug1JWtK-Nn7W23Wl5QIxhpGyBO0KnNd1Q29eYpWhDBadawRJ-hFSreknLOOPkcnlPKOcE5W6E-Pv4UMPuPrB59HyM7g7c0V7nfBu5TxRcKXIQI-HwYw2d0DzqPyeDOGCVKGGCa8Dco6v8Oq0N4uZj_3HzY9xfPVlx4rb_F1dvMyqbx_-jdaWqfl90v0bFBTglfH-xT9-Hj-ffO52n79dLHpt5VpiMiVEWRoCWeME227bhhq0K3lDRWtbhqlQAg9WK2Bd6bTQNuiwqoOBqZNrQitT9G7Q-9dDD-XsoOcXTIwTcpDWJKkoia0FXUB1wfQxJBShEHeRTer-CApkXvtsmiXj9pL4M2xedEz2Ef86LkAbw_A6HbjLxdBahfMCLNknEvKSmv5q4KJAwZFw72DKJNx4A3YEjFZ2uD-t8Jf2OOdHA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18301683</pqid></control><display><type>article</type><title>A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Sparrow, Carl P. ; Baffic, Joanne ; Lam, My-Hanh ; Lund, Erik G. ; Adams, Alan D. ; Fu, Xuan ; Hayes, Nancy ; Jones, A. Brian ; Macnaul, Karen L. ; Ondeyka, John ; Singh, Sheo ; Wang, Jianhua ; Zhou, Gaochao ; Moller, David E. ; Wright, Samuel D. ; Menke, John G.</creator><creatorcontrib>Sparrow, Carl P. ; Baffic, Joanne ; Lam, My-Hanh ; Lund, Erik G. ; Adams, Alan D. ; Fu, Xuan ; Hayes, Nancy ; Jones, A. Brian ; Macnaul, Karen L. ; Ondeyka, John ; Singh, Sheo ; Wang, Jianhua ; Zhou, Gaochao ; Moller, David E. ; Wright, Samuel D. ; Menke, John G.</creatorcontrib><description>The LXR nuclear receptors are intracellular sensors of cholesterol excess and are activated by various oxysterols. LXRs have been shown to regulate multiple genes of lipid metabolism, including ABCA1 (formerly known asABC1). ABCA1 is a lipid pump that effluxes cholesterol and phospholipid out of cells. ABCA1 deficiency causes extremely low high density lipoprotein (HDL) levels, demonstrating the importance of ABCA1 in the formation of HDL. The present work shows that the acetyl-podocarpic dimer (APD) is a potent, selective agonist for both LXRα (NR1H3) and LXRβ (NR1H2). In transient transactivation assays, APD was ∼1000-fold more potent, and yielded ∼6-fold greater maximal stimulation, than the widely used LXR agonist 22-(R)-hydroxycholesterol. APD induced ABCA1mRNA levels, and increased efflux of both cholesterol and phospholipid, from multiple cell types. Gas chromatography-mass spectrometry measurements demonstrated that APD stimulated efflux of endogenous cholesterol, eliminating any possible artifacts of cholesterol labeling. For both mRNA induction and stimulation of cholesterol efflux, APD was found to be more effective than was cholesterol loading. Taken together, these data show that APD is a more effective LXR agonist than endogenous oxysterols. LXR agonists may therefore be useful for the prevention and treatment of atherosclerosis, especially in the context of low HDL levels.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M108225200</identifier><identifier>PMID: 11790770</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>ABCA1 gene ; Abietanes ; ATP Binding Cassette Transporter 1 ; ATP-Binding Cassette Transporters - metabolism ; Biological Transport ; Cell Line ; Cells, Cultured ; Cholesterol - metabolism ; Cholesterol - pharmacology ; Dimerization ; DNA-Binding Proteins ; Dose-Response Relationship, Drug ; Fibroblasts - metabolism ; Gas Chromatography-Mass Spectrometry ; Humans ; Ligands ; Lipoproteins, HDL - metabolism ; Liver X Receptors ; LXR protein ; Macrophages - metabolism ; Models, Chemical ; Orphan Nuclear Receptors ; Phenanthrenes - chemistry ; Phenanthrenes - metabolism ; phospholipids ; Phospholipids - metabolism ; Protein Binding ; Receptors, Cytoplasmic and Nuclear - agonists ; RNA, Messenger - metabolism ; Transcriptional Activation ; Tumor Cells, Cultured</subject><ispartof>The Journal of biological chemistry, 2002-03, Vol.277 (12), p.10021-10027</ispartof><rights>2002 © 2002 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-c80f6072270bd99ff3eb6d75186b55aae88bfdbbe79c9be16108da9ef2bc3a013</citedby><cites>FETCH-LOGICAL-c508t-c80f6072270bd99ff3eb6d75186b55aae88bfdbbe79c9be16108da9ef2bc3a013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11790770$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sparrow, Carl P.</creatorcontrib><creatorcontrib>Baffic, Joanne</creatorcontrib><creatorcontrib>Lam, My-Hanh</creatorcontrib><creatorcontrib>Lund, Erik G.</creatorcontrib><creatorcontrib>Adams, Alan D.</creatorcontrib><creatorcontrib>Fu, Xuan</creatorcontrib><creatorcontrib>Hayes, Nancy</creatorcontrib><creatorcontrib>Jones, A. Brian</creatorcontrib><creatorcontrib>Macnaul, Karen L.</creatorcontrib><creatorcontrib>Ondeyka, John</creatorcontrib><creatorcontrib>Singh, Sheo</creatorcontrib><creatorcontrib>Wang, Jianhua</creatorcontrib><creatorcontrib>Zhou, Gaochao</creatorcontrib><creatorcontrib>Moller, David E.</creatorcontrib><creatorcontrib>Wright, Samuel D.</creatorcontrib><creatorcontrib>Menke, John G.</creatorcontrib><title>A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>The LXR nuclear receptors are intracellular sensors of cholesterol excess and are activated by various oxysterols. LXRs have been shown to regulate multiple genes of lipid metabolism, including ABCA1 (formerly known asABC1). ABCA1 is a lipid pump that effluxes cholesterol and phospholipid out of cells. ABCA1 deficiency causes extremely low high density lipoprotein (HDL) levels, demonstrating the importance of ABCA1 in the formation of HDL. The present work shows that the acetyl-podocarpic dimer (APD) is a potent, selective agonist for both LXRα (NR1H3) and LXRβ (NR1H2). In transient transactivation assays, APD was ∼1000-fold more potent, and yielded ∼6-fold greater maximal stimulation, than the widely used LXR agonist 22-(R)-hydroxycholesterol. APD induced ABCA1mRNA levels, and increased efflux of both cholesterol and phospholipid, from multiple cell types. Gas chromatography-mass spectrometry measurements demonstrated that APD stimulated efflux of endogenous cholesterol, eliminating any possible artifacts of cholesterol labeling. For both mRNA induction and stimulation of cholesterol efflux, APD was found to be more effective than was cholesterol loading. Taken together, these data show that APD is a more effective LXR agonist than endogenous oxysterols. LXR agonists may therefore be useful for the prevention and treatment of atherosclerosis, especially in the context of low HDL levels.</description><subject>ABCA1 gene</subject><subject>Abietanes</subject><subject>ATP Binding Cassette Transporter 1</subject><subject>ATP-Binding Cassette Transporters - metabolism</subject><subject>Biological Transport</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>Cholesterol - metabolism</subject><subject>Cholesterol - pharmacology</subject><subject>Dimerization</subject><subject>DNA-Binding Proteins</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fibroblasts - metabolism</subject><subject>Gas Chromatography-Mass Spectrometry</subject><subject>Humans</subject><subject>Ligands</subject><subject>Lipoproteins, HDL - metabolism</subject><subject>Liver X Receptors</subject><subject>LXR protein</subject><subject>Macrophages - metabolism</subject><subject>Models, Chemical</subject><subject>Orphan Nuclear Receptors</subject><subject>Phenanthrenes - chemistry</subject><subject>Phenanthrenes - metabolism</subject><subject>phospholipids</subject><subject>Phospholipids - metabolism</subject><subject>Protein Binding</subject><subject>Receptors, Cytoplasmic and Nuclear - agonists</subject><subject>RNA, Messenger - metabolism</subject><subject>Transcriptional Activation</subject><subject>Tumor Cells, Cultured</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1v1DAURS0EokNhyxJ5gdhlsJ0mdpZhVKDSFFALUneWP14mrhK72E6ha_44Hs1IZYM3fpLPvXo6Rug1JWtK-Nn7W23Wl5QIxhpGyBO0KnNd1Q29eYpWhDBadawRJ-hFSreknLOOPkcnlPKOcE5W6E-Pv4UMPuPrB59HyM7g7c0V7nfBu5TxRcKXIQI-HwYw2d0DzqPyeDOGCVKGGCa8Dco6v8Oq0N4uZj_3HzY9xfPVlx4rb_F1dvMyqbx_-jdaWqfl90v0bFBTglfH-xT9-Hj-ffO52n79dLHpt5VpiMiVEWRoCWeME227bhhq0K3lDRWtbhqlQAg9WK2Bd6bTQNuiwqoOBqZNrQitT9G7Q-9dDD-XsoOcXTIwTcpDWJKkoia0FXUB1wfQxJBShEHeRTer-CApkXvtsmiXj9pL4M2xedEz2Ef86LkAbw_A6HbjLxdBahfMCLNknEvKSmv5q4KJAwZFw72DKJNx4A3YEjFZ2uD-t8Jf2OOdHA</recordid><startdate>20020322</startdate><enddate>20020322</enddate><creator>Sparrow, Carl P.</creator><creator>Baffic, Joanne</creator><creator>Lam, My-Hanh</creator><creator>Lund, Erik G.</creator><creator>Adams, Alan D.</creator><creator>Fu, Xuan</creator><creator>Hayes, Nancy</creator><creator>Jones, A. Brian</creator><creator>Macnaul, Karen L.</creator><creator>Ondeyka, John</creator><creator>Singh, Sheo</creator><creator>Wang, Jianhua</creator><creator>Zhou, Gaochao</creator><creator>Moller, David E.</creator><creator>Wright, Samuel D.</creator><creator>Menke, John G.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope></search><sort><creationdate>20020322</creationdate><title>A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux</title><author>Sparrow, Carl P. ; Baffic, Joanne ; Lam, My-Hanh ; Lund, Erik G. ; Adams, Alan D. ; Fu, Xuan ; Hayes, Nancy ; Jones, A. Brian ; Macnaul, Karen L. ; Ondeyka, John ; Singh, Sheo ; Wang, Jianhua ; Zhou, Gaochao ; Moller, David E. ; Wright, Samuel D. ; Menke, John G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-c80f6072270bd99ff3eb6d75186b55aae88bfdbbe79c9be16108da9ef2bc3a013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>ABCA1 gene</topic><topic>Abietanes</topic><topic>ATP Binding Cassette Transporter 1</topic><topic>ATP-Binding Cassette Transporters - metabolism</topic><topic>Biological Transport</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>Cholesterol - metabolism</topic><topic>Cholesterol - pharmacology</topic><topic>Dimerization</topic><topic>DNA-Binding Proteins</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fibroblasts - metabolism</topic><topic>Gas Chromatography-Mass Spectrometry</topic><topic>Humans</topic><topic>Ligands</topic><topic>Lipoproteins, HDL - metabolism</topic><topic>Liver X Receptors</topic><topic>LXR protein</topic><topic>Macrophages - metabolism</topic><topic>Models, Chemical</topic><topic>Orphan Nuclear Receptors</topic><topic>Phenanthrenes - chemistry</topic><topic>Phenanthrenes - metabolism</topic><topic>phospholipids</topic><topic>Phospholipids - metabolism</topic><topic>Protein Binding</topic><topic>Receptors, Cytoplasmic and Nuclear - agonists</topic><topic>RNA, Messenger - metabolism</topic><topic>Transcriptional Activation</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sparrow, Carl P.</creatorcontrib><creatorcontrib>Baffic, Joanne</creatorcontrib><creatorcontrib>Lam, My-Hanh</creatorcontrib><creatorcontrib>Lund, Erik G.</creatorcontrib><creatorcontrib>Adams, Alan D.</creatorcontrib><creatorcontrib>Fu, Xuan</creatorcontrib><creatorcontrib>Hayes, Nancy</creatorcontrib><creatorcontrib>Jones, A. Brian</creatorcontrib><creatorcontrib>Macnaul, Karen L.</creatorcontrib><creatorcontrib>Ondeyka, John</creatorcontrib><creatorcontrib>Singh, Sheo</creatorcontrib><creatorcontrib>Wang, Jianhua</creatorcontrib><creatorcontrib>Zhou, Gaochao</creatorcontrib><creatorcontrib>Moller, David E.</creatorcontrib><creatorcontrib>Wright, Samuel D.</creatorcontrib><creatorcontrib>Menke, John G.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sparrow, Carl P.</au><au>Baffic, Joanne</au><au>Lam, My-Hanh</au><au>Lund, Erik G.</au><au>Adams, Alan D.</au><au>Fu, Xuan</au><au>Hayes, Nancy</au><au>Jones, A. Brian</au><au>Macnaul, Karen L.</au><au>Ondeyka, John</au><au>Singh, Sheo</au><au>Wang, Jianhua</au><au>Zhou, Gaochao</au><au>Moller, David E.</au><au>Wright, Samuel D.</au><au>Menke, John G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2002-03-22</date><risdate>2002</risdate><volume>277</volume><issue>12</issue><spage>10021</spage><epage>10027</epage><pages>10021-10027</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>The LXR nuclear receptors are intracellular sensors of cholesterol excess and are activated by various oxysterols. LXRs have been shown to regulate multiple genes of lipid metabolism, including ABCA1 (formerly known asABC1). ABCA1 is a lipid pump that effluxes cholesterol and phospholipid out of cells. ABCA1 deficiency causes extremely low high density lipoprotein (HDL) levels, demonstrating the importance of ABCA1 in the formation of HDL. The present work shows that the acetyl-podocarpic dimer (APD) is a potent, selective agonist for both LXRα (NR1H3) and LXRβ (NR1H2). In transient transactivation assays, APD was ∼1000-fold more potent, and yielded ∼6-fold greater maximal stimulation, than the widely used LXR agonist 22-(R)-hydroxycholesterol. APD induced ABCA1mRNA levels, and increased efflux of both cholesterol and phospholipid, from multiple cell types. Gas chromatography-mass spectrometry measurements demonstrated that APD stimulated efflux of endogenous cholesterol, eliminating any possible artifacts of cholesterol labeling. For both mRNA induction and stimulation of cholesterol efflux, APD was found to be more effective than was cholesterol loading. Taken together, these data show that APD is a more effective LXR agonist than endogenous oxysterols. LXR agonists may therefore be useful for the prevention and treatment of atherosclerosis, especially in the context of low HDL levels.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11790770</pmid><doi>10.1074/jbc.M108225200</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2002-03, Vol.277 (12), p.10021-10027
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_18301683
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects ABCA1 gene
Abietanes
ATP Binding Cassette Transporter 1
ATP-Binding Cassette Transporters - metabolism
Biological Transport
Cell Line
Cells, Cultured
Cholesterol - metabolism
Cholesterol - pharmacology
Dimerization
DNA-Binding Proteins
Dose-Response Relationship, Drug
Fibroblasts - metabolism
Gas Chromatography-Mass Spectrometry
Humans
Ligands
Lipoproteins, HDL - metabolism
Liver X Receptors
LXR protein
Macrophages - metabolism
Models, Chemical
Orphan Nuclear Receptors
Phenanthrenes - chemistry
Phenanthrenes - metabolism
phospholipids
Phospholipids - metabolism
Protein Binding
Receptors, Cytoplasmic and Nuclear - agonists
RNA, Messenger - metabolism
Transcriptional Activation
Tumor Cells, Cultured
title A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T02%3A19%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Potent%20Synthetic%20LXR%20Agonist%20Is%20More%20Effective%20than%20Cholesterol%20Loading%20at%20Inducing%20ABCA1%20mRNA%20and%20Stimulating%20Cholesterol%20Efflux&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Sparrow,%20Carl%20P.&rft.date=2002-03-22&rft.volume=277&rft.issue=12&rft.spage=10021&rft.epage=10027&rft.pages=10021-10027&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M108225200&rft_dat=%3Cproquest_cross%3E18301683%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18301683&rft_id=info:pmid/11790770&rft_els_id=S0021925819361290&rfr_iscdi=true